Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein has appointed Mark Hillebrandt as Vice President and Chief Digital Revenue Officer, focusing on e-commerce growth as part of the company’s 2022-2024 “BOLD+1” Strategic Plan. Hillebrandt will lead a new Digital Revenue Team aimed at enhancing online customer engagement and digital transactions. His role will support the advancement of Henry Schein's e-commerce tools, thereby improving customer experience and expanding the sales team's capabilities. Hillebrandt brings nearly 15 years of industry experience, previously holding leadership roles at Amazon and KaVo Kerr.
Henry Schein, Inc. (NASDAQ: HSIC) announced the appointments of Trinh Clark as Chief Global Customer Experience Officer and Leigh Benowitz as Chief Global Digital Transformation Officer. These appointments are part of the strategic implementation of the 2022-2024 BOLD+1 plan, aimed at enhancing customer experience and accelerating digital technology adoption. Clark will lead a new Global Customer Experience Organization, while Benowitz will focus on digital commerce initiatives. Both executives bring substantial experience to their roles, aligning with the company's goal of improving operational success for healthcare providers.
Henry Schein, the largest provider of health care solutions to dental and medical practitioners, will release its second-quarter 2022 financial results on August 2, 2022, before market opening. A live webcast of the earnings call will begin at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the call through the company's website. Henry Schein continues to serve over 1 million customers globally, offering a vast range of health care solutions.
Arc Health sponsors a luncheon at the National Press Club to honor Dr. Mary McLeod Bethune's legacy and promote health equity. The event features keynote speaker Mayor Jereleen Hollimon-Miller and includes a panel of notable guests discussing preventive health awareness. The panelists, including Rev. Dr. Johnnie Green Jr. and Karen Huger, will address health disparities and the importance of preventive services. CEO Paul Adams emphasizes the need for improved healthcare in underserved communities. Arc Health and Medpod demonstrate virtual preventive health solutions during the event.
Henry Schein, Inc. (Nasdaq: HSIC) has acquired Condor Dental Research Company SA, expanding its dental distribution in Switzerland. This complete acquisition from MCCB II Holding is projected to have a neutral impact on HSIC's 2022 diluted earnings per share and be accretive thereafter. Condor Dental, established in 1978 with 2021 sales of approximately $18 million, specializes in dental consumables and lab installations. The integration of Condor Dental aims to enhance services and expand geographic reach for Henry Schein in the Swiss market.
Henry Schein Cares Foundation announces the appointment of Maureen Knott as President, succeeding Steve W. Kess, who becomes President Emeritus. Ms. Knott, a 35-year veteran of the company, aims to enhance access to care and spearhead initiatives to innovate health care systems. The Foundation focuses on wellness, access to care, disaster response, and supports health care professionals. Under her leadership, it has raised over $2 million for various health initiatives. The Foundation is committed to building a healthier world.
Henry Schein (Nasdaq: HSIC) announced an agreement to acquire Condor Dental Research Company SA, enhancing its presence in the Swiss dental distribution market. Condor, established in 1978, reported $18 million in sales in 2021, primarily from dental consumables. The acquisition is expected to be neutral to diluted earnings per share in 2022 and accretive thereafter. This strategic move aligns with Henry Schein's commitment to expand its offerings and improve services in the dental sector across Europe.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, presented at the William Blair Emerging Technologies in Dental Care Virtual Investor Conference on May 17, 2022. A replay will be accessible on their investor presentations webpage starting May 19, 2022, for up to two weeks. The company reported sales of $12.4 billion in 2021, with a 12.5% compound annual growth rate since going public in 1995. Henry Schein serves over 1 million customers globally through a network of nearly 22,000 Team Schein Members.
Henry Schein, the largest provider of healthcare solutions for dental and medical practitioners, announced its participation in two upcoming investor conferences in June 2022. The events include the Stifel 2022 Annual Dental & Veterinary Conference on June 1 and the Jefferies 2022 Healthcare Conference on June 9. Live webcasts of the presentations will be available on Henry Schein's investor relations website. The company highlights its extensive global network, serving over 1 million customers with more than 300 solutions aimed at enhancing operational success and clinical outcomes.
Henry Schein has appointed Dirk Benson as Vice President and Chief Commercial Officer of its North America Distribution Group. His role will focus on driving the 'One Distribution' strategy to enhance efficiency and customer experience. Nancy Lanni has been named Vice President and General Manager of the new Strategic Account Management Team. Both executives bring extensive expertise from the health care industry and will play a key role in implementing the company's 2022-2024 BOLD+1 Strategic Plan.